Niva Bupa Health Insurance Co. Ltd. (NIVABUPA) — key facts
NSE-listed · Financial Services. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹75.65 (-1.86% day change)
Key ratios
- P/E ratio
- 106.55
- P/B ratio
- 4.05
- ROE (%)
- 4.09
- ROCE (%)
- 1.12
- Debt/Equity
- 0.08
- Dividend yield (%)
- 0
- Market cap (₹ Cr)
- 13,992.56
Financial health
Industrial forensic models are not applicable. InvestSights does not yet publish an insurer solvency framework.
InvestSights quality score
45.8/100 — Below Average (descriptive data-driven composite; not a recommendation)
Management guidance track record
- Cashless claims processed in under 30 minutes: guided 90%, delivered 84.3% (FY26) — missed guidance
- Claims Settlement Ratio: guided 92–93%, delivered 94.4% (FY26) — exceeded guidance
Latest earnings call (Q2 FY27)
AI summary: The central signal is that Niva Bupa’s H1 improvement was not presented as merely a benign claims-frequency outcome; management attributed it mainly to stronger retail mix, higher-quality fresh business and disciplined avoidance of underpriced group policies. Retail growth remained high at 47% on a reported basis, while the retail loss ratio improved to 67.4% and the combined…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.